Statistical analysis was performed with R software (www.R-project.org) and packages available through Bioconductor(www.bioconductor.org). Quality control was performed, as previously described.63 Expression values were obtained by using the GC Robust Multiarray Average algorithm. Batch effects were removed by identifying and adjusting for surrogate variables with the sva package.70 Probe sets with 15 or more samples and expression values of greater than 3 were kept for analysis. Data were log2-transformed and fitted with a linear model. Fold changes (FCHs) between comparisons of interest were estimated, and hypothesis testing was conducted by using contrasts under the general framework for linear models in the R software limma package. P values from the moderated (paired) t test were adjusted for multiple hypotheses by using the Benjamini-Hochberg procedure. Genes with FCHs of greater than 2 and a false discovery rate (FDR) of less than 0.05 were considered differentially expressed. Hierarchical clustering of samples/conditions used a McQuitty agglomeration algorithm. Gene-set variance analysis was performed by using unsupervised sample-wise enrichment.71 Gene-set overrepresentation analysis was performed with XGR software72 and crowd-extracted expression of differential signature disease signatures.73
All 29 samples from patients with ichthyoses, 21 control subjects, and 10 patients with psoriasis and AD were available for RT-PCR analyses. mRNA expression RT-PCR data were log2-transformed and fitted to a linear model as above. Values of less than the limit of detection were imputed as 20% of the minimal value over the limit of detection, as previously eported.74 See the Methods section in this article’s Online Repository for details.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.